Quarterly report pursuant to Section 13 or 15(d)

Warrants (Details)

v3.4.0.3
Warrants (Details)
3 Months Ended
Mar. 31, 2016
$ / shares
shares
Warrants [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Number of Shares Underlying Warrants Originally Granted 375,000
Shares Underlying Warrants Exchanged, Exercised or Expired (196,307)
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 1,136,878
Exercise Price | $ / shares $ 7.00
Series A Warrants [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Grant Date Jan. 27, 2014 [1]
Number of Shares Underlying Warrants Originally Granted 315,676 [1]
Shares Underlying Warrants Exchanged, Exercised or Expired [1]
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 315,676 [1]
Exercise Price | $ / shares $ 15.00 [1]
Expiration Term in Years 9 months 29 days [1]
Series B Warrants [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Grant Date Jan. 27, 2014 [1]
Number of Shares Underlying Warrants Originally Granted 157,846 [1]
Shares Underlying Warrants Exchanged, Exercised or Expired [1]
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 157,846 [1]
Exercise Price | $ / shares $ 45.00 [1]
Expiration Term in Years 2 years 9 months 26 days [1]
Series C Warrants [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Grant Date Nov. 19, 2014 [2]
Number of Shares Underlying Warrants Originally Granted 145,399 [2]
Shares Underlying Warrants Exchanged, Exercised or Expired (142,957) [2]
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 2,442 [2]
Exercise Price | $ / shares $ 12 [2]
Expiration Term in Years 4 years 1 month 17 days [2]
Series C Warrants [Member] | Revised [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Number of Shares Underlying Warrants Originally Granted [2]
Shares Underlying Warrants Exchanged, Exercised or Expired 142,957 [2]
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 142,957 [2]
Exercise Price | $ / shares $ 9 [2]
Expiration Term in Years 4 years 1 month 17 days [2]
Series D Warrants [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Grant Date Nov. 19, 2014 [2]
Number of Shares Underlying Warrants Originally Granted 193,865 [2]
Shares Underlying Warrants Exchanged, Exercised or Expired (193,865) [2]
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 [2]
Exercise Price | $ / shares [2]
Expiration Term in Years 0 years [2]
Series E Warrants [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Grant Date Nov. 19, 2014 [2]
Number of Shares Underlying Warrants Originally Granted 145,399 [2]
Shares Underlying Warrants Exchanged, Exercised or Expired (145,399) [2]
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 [2]
Exercise Price | $ / shares [2]
Expiration Term in Years 0 years [2]
Series E Warrants [Member] | Revised [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Shares Underlying Warrants Exchanged, Exercised or Expired 142,957 [2]
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 142,957 [2]
Exercise Price | $ / shares $ 9.00 [2]
Expiration Term in Years 6 years 1 month 17 days [2]
First Closing [Member]  
Summary of warrants issued to private placement stockholders and consultants  
Grant Date Mar. 03, 2016 [3]
Number of Shares Underlying Warrants Originally Granted 375,000 [3]
Shares Underlying Warrants Exchanged, Exercised or Expired [3]
Shares Underlying Warrants Outstanding and Exercisable at March 31, 2016 375,000 [3]
Exercise Price | $ / shares $ 7.00 [3]
Expiration Term in Years 4 years 11 months 1 day [3]
[1] Issued in connection with the January 27, 2014 private placement transaction.
[2] Issued in connection with the November 19, 2014 registered-direct public offering, and subsequently revised pursuant to Warrant Exercise Agreements entered into on May 18, 2015.
[3] Issued upon the closing of the first tranche of the Financing with Rens Technology Inc. on March 3, 2016.